The Clinical Cancer Research Unit is composed of several teams that have as a common theme the application and conduct of clinical studies. Jim Paul is senior statistician at the CR-UK clinical trials unit and has a pivotal role in the management and conduct of our (mainly) large-scale randomised controlled trials. Rob Jones is Director of the CTU, and both he and Hing Leung are both lead figures in the field of urological oncology. Hing also leads his own Beatson Institute group. Anthony Chalmers is the Chair of Radiation Oncology. His main research interest is in the mechanisms of DNA repair, which obviously fits well with several other groups in Glasgow. His clinical interest is in brain cancers and he is currently PI for a CR-UK sponsored trial in this disease that incorporates several translational endpoints pertinent to his own lab programme (which is currently MRC supported).
The Radiotherapy Research Group, led by Stefano Schipani, has been launched with the aim to initiate, facilitate, execute and publish high quality, innovative and clinically relevant research that will establish Glasgow as a leading international centre for academic radiotherapy research and will lead to better treatments for cancer patients. Early phase clinical trials and translational clinical studies are developed and led through the Glasgow ECMC (Lead: Jeff Evans). Chloe Cowan, CR-UK Senior Research and Information Nurse, leads on public engagement and education, which remain important themes for our clinical research programmes.